Methylene Blue is a Monoamine Oxidase Inhibitor; Severe Harm and Death Associated with Low-Dose Methotrexate;

Michael R Cohen1, Judy L Smetzer2

  • 1Institute for Safe Medication Practices, 200 Lakeside Drive, Suite 200, Horsham, PA 19044.

Hospital Pharmacy
|May 15, 2024
PubMed

Insights

Medication errors are common in healthcare facilities but can be prevented through staff education and procedural safeguards. Reporting errors to programs like the Institute for Safe Medication Practices (ISMP) aids in this prevention.

Area of Science:

  • Healthcare Safety
  • Medication Error Prevention
  • Patient Safety

Background:

  • Medication errors represent a significant risk in healthcare settings.
  • These errors are recurrent and pose a threat to patient well-being.
  • Proactive measures are essential to mitigate medication-related adverse events.

Purpose of the Study:

  • To highlight the persistent issue of medication errors in healthcare facilities.
  • To emphasize the importance of education, alertness, and procedural safeguards in error prevention.
  • To encourage healthcare professionals to report medication errors and near misses.

Main Methods:

  • Utilizing reports submitted to the Institute for Safe Medication Practices (ISMP) Medication Errors Reporting Program.
  • Anonymizing reported errors for publication and educational purposes.
  • Providing channels for direct reporting of errors, close calls, and hazardous conditions via website, phone, and email.

Main Results:

  • Analysis of reported medication errors indicates their frequent occurrence in healthcare.
  • The ISMP program serves as a crucial platform for collecting and disseminating information on medication errors.
  • Confidentiality and reporter anonymity are guaranteed to encourage participation.

Conclusions:

  • Medication errors are preventable through enhanced personnel education and robust procedural safeguards.
  • Active participation in reporting systems like ISMP is vital for collective learning and improving patient safety.
  • Continuous vigilance and open communication are key to reducing the incidence of medication errors.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.9K
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
180
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
13.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Mismatch Repair01:36

Mismatch Repair

Overview
40.1K